<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03690180</url>
  </required_header>
  <id_info>
    <org_study_id>VCG5</org_study_id>
    <nct_id>NCT03690180</nct_id>
  </id_info>
  <brief_title>Hypomagnesemia and Diabetic Nephropathy</brief_title>
  <official_title>Hypomagnesemia as a Marker of Diabeteiv Nephropathy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fayoum University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fayoum University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To find if there is a corrolatation between Microalbuminurea and diabetic retinopathy, in
      daibetic patients
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      40 Daibetic patients with microalbuminurea will be subjeted to full clinical examination and
      fundus examination,20 control diabetics with out microalbuminurea will also be included for
      comparison,patients will be selected from the outpatient clinic 0f fayoum university
      hospital.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2018</start_date>
  <completion_date type="Actual">February 28, 2018</completion_date>
  <primary_completion_date type="Actual">January 30, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Decrease in serum magnesium</measure>
    <time_frame>One month</time_frame>
    <description>statistical significant change in serum magnesium in diabetics with microalbuminuria</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">100</enrollment>
  <condition>Diabetic Nephropathies</condition>
  <arm_group>
    <arm_group_label>Diabetics with microalbuminuria</arm_group_label>
    <description>Diabetics with micro albuminuria will be subjected to full clinical examination.
Measurement of weight, height, waist, hip and calculation of BMI and waist hip ratio,laboratory assessment of serum creatinine,HbA1C,magnesium and urinary albumin creatinine ratio</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Diabetics with normal albuminuria</arm_group_label>
    <description>Diabetics with micro albuminuria will be subjected to full clinical examination.
Measurement of weight, height, waist, hip and calculation of BMI and waist hip ratio,laboratory assessment of serum creatinine,HbA1C,magnesium and urinary albumin creatinine ratio</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>serum magnesium</intervention_name>
    <description>assessment of serum magnesium in all patients</description>
    <arm_group_label>Diabetics with microalbuminuria</arm_group_label>
    <arm_group_label>Diabetics with normal albuminuria</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Diabetic patients following up in out patient clinic of diabetes and endocrine ,Fayoum
        university Hospital
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diabetics on oral treatment,diabetics on insulin

        Exclusion Criteria:

          -  Healthy volunteers,,hypertensive patients with normal blood glucose
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Faculty of medicine Fayoum univesity</name>
      <address>
        <city>Fayoum</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>March 31, 2018</study_first_submitted>
  <study_first_submitted_qc>September 27, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 1, 2018</study_first_posted>
  <last_update_submitted>September 6, 2019</last_update_submitted>
  <last_update_submitted_qc>September 6, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 10, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Fayoum University</investigator_affiliation>
    <investigator_full_name>Ahmed Abdelkawi Hammad</investigator_full_name>
    <investigator_title>Lecturer of Medicine,Faculty of Medicine,Fayoum university</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Diabetic Nephropathies</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

